Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava

Area of Science:

• Oncology
• Surgical Oncology
• Urology

Background:

• Nonseminomatous germ-cell cancer can metastasize to the retroperitoneum.
• Advanced cases may involve the inferior vena cava, necessitating complex surgical intervention.
• Post-chemotherapy retroperitoneal lymph-node dissection (RPLND) is a standard treatment for residual disease.

Purpose of the Study:

• To evaluate the indications, outcomes, and complications of inferior vena cava (IVC) resection or thrombectomy during RPLND for bulky metastatic nonseminomatous germ-cell cancer.
• To determine the oncological justification for IVC resection based on nodal and thrombus pathology.
• To assess the survival benefit of this aggressive surgical approach in patients with refractory disease.

Main Methods:

• Retrospective analysis of 42 patients undergoing RPLND with IVC resection (n=40) or thrombectomy (n=2).
• Indications for IVC intervention: tumor clearance, caval scar occlusion, and intraluminal tumor thrombus.
• Pathological analysis of resected specimens to correlate IVC findings with nodal pathology.

Main Results:

• IVC resection/thrombectomy was performed in 7% of post-chemotherapy RPLND cases.
• Primary indications were tumor thrombus (48%), tumor clearance (38%), and scar occlusion (14%).
• Pathology confirmed cancer/teratoma in resected specimens, justifying the intervention, with overall 71% survival.

Conclusions:

• Inferior vena cava resection/thrombectomy is a feasible and oncologically sound procedure for selected patients with bulky metastatic nonseminomatous germ-cell cancer.
• This approach provides a survival benefit for patients with refractory disease who have exhausted chemotherapy options.
• Complications associated with IVC intervention were generally transient, supporting its role in multidisciplinary cancer care.